The University of Chicago Comprehensive Cancer Center
Founded in 1973, The University of Chicago Medicine Comprehensive Cancer Center received its NCI designation that same year and its designation as a comprehensive cancer center in 2008.
The Comprehensive Cancer Center has a long tradition in clinical and basic science, cancer research and training, and in cancer care. Population studies are a more recent area of expertise. The Comprehensive Cancer Center’s mission is to improve the understanding of the determinants of cancer, its prevention, and its treatment.
Research programs at the Comprehensive Cancer Center have long emphasized advances in chemotherapy, hormonal therapy, gene therapy, and bone marrow transplantation. Laboratory research programs cover the molecular genetics of cancer, cancer immunology, cell signaling, pharmacogenomics, computational biology, and advanced imaging techniques. Clinical work on specific cancers includes breast, head and neck, lung, kidney, bladder, prostate, cervical, ovarian, colorectal, skin, thyroid, pancreas, brain, esophagus and stomach cancers, as well as leukemia, lymphoma, myeloma, and mesothelioma. Population research emphasizes identifying genetic, behavioral and environmental risk factors for cancer, advancing cancer prevention strategies, and understanding early detection, health disparities, and quality-of-life issues.
Patient care and treatment takes place at University of Chicago Medicine, where more than 4,000 cancer patients are diagnosed and/or treated annually. At the core of the medical campus is the 10-story, 1.2-million-square-foot Center for Care and Discovery, a “hospital for the future” that opened in February 2013 and is designed to accommodate the changing needs of patient care and clinical research for decades to come. With an entire floor devoted to cancer treatment, including a 28-bed stem cell and bone marrow transplant unit, the hospital expands capacity to patients from local communities and from around the world.
The Comprehensive Cancer Center enrolls more than 1,000 patients in clinical trials each year. The hospital campus is adjacent to two facilities for research: the Gordon Center for Integrative Science, which encourages research collaborations and the Knapp Center for Biomedical Discovery. The Knapp Center includes lab space for Comprehensive Cancer Center investigators and houses the Ludwig Center for Metastasis Research, the Institute for Genomics and Systems Biology, and the hematology and oncology research programs for the departments of medicine and pediatrics.
The Comprehensive Cancer Center’s interdisciplinary scientific programs include molecular mechanisms of cancer, hematopoiesis and hematological malignancies, immunology and cancer, pharmacogenomics and experimental therapeutics, advanced imaging, and cancer prevention and control. Several collaborative research programs, such as the Specialized Program in Research Excellence (SPORE) in Prostate Cancer, take place in conjunction with the Lurie Comprehensive Cancer Center of Northwestern University.
Located on the south side of Chicago, the Comprehensive Cancer Center has a strong reputation for providing care to underserved populations and emphasizing research on health disparities aimed at reducing or eliminating these disparities.
* This profile was provided by the University of Chicago Comprehensive Cancer Center.